Brain metastasis risk prediction for hormone-positive breast cancer
Part of Cancer, Skin clinical trials.
This study tests a model to predict which patients with hormone receptor (HR)-positive breast cancer may develop brain metastases later. It may help identify patients who need extra monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hormone receptor (HR)-positive breast cancer.
- You did not have brain metastases when first diagnosed or within three months after.
- You do not have breast cancer in both breasts.
- You do not have another cancer at the same time, such as lung cancer or melanoma.
- You have complete medical records from when you were first diagnosed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether routine brain scans can help manage breast cancer that has spread to other parts of the body. It aims to find brain metastases early in people with certain types of high-risk breast cancer, even before symptoms appear.
This study looks at factors that affect survival in breast cancer patients whose cancer has spread to the brain. The goal is to learn more about what influences outcomes, which may help guide future treatment decisions.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This study is testing regular MRI brain scans to find any brain metastases early in people with HER2-positive breast cancer that has spread. It aims to see if early detection can help guide treatment and improve outcomes.
This study uses advanced computer models to predict how likely lung cancer is to spread to the brain and how it may affect your health. It includes people with lung cancer who are getting standard treatment and have had recent MRI and CT scans.
Hear when a new Breast Cancer, Estrogen Receptor-Positive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.